Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition

Science
G PateyE Soroca-Lucas

Abstract

Methionine enkephalin release was evoked by depolarization of slices from rat striatum with potassium. In the presence of 0.1 microM thiorphan [(N(R,S)-3-mercapto-2-benzylpropionyl)glycine], a potent inhibitor of enkephalin dipeptidyl carboxypeptidase (enkephalinase), the recovery of the pentapeptide in the incubation medium was increased by about 100 percent. A similar effect was observed with the dipeptide phenylalanylalanine, a selective although less potent enkephalinase inhibitor. Inhibition of other known enkephalin-hydrolyzing enzymes--aminopeptidase by 0.1 mM puromycin or angiotensin-converting enzyme by 1 microM captopril--did not significantly enhance the recovery of released methionine enkephalin. These data indicate that enkephalinase is critically involved in the inactivation of the endogenous opioid peptide released from striatal neurons.

References

Feb 16, 1978·Nature·G HendersonH W Kosterlitz
Feb 16, 1978·Nature·L L IversenR Guillemin
Jan 1, 1979·European Journal of Pharmacology·J P SwertsJ C Schwartz
Nov 15, 1979·Biochemical Pharmacology·E J SimonR B Merrifield
Feb 1, 1977·Neuropharmacology·J L MeekE Costa
Feb 1, 1979·Clinical Science·H K RichardsK A Munday
Mar 15, 1978·European Journal of Pharmacology·H OsborneA Herz
Nov 13, 1978·Life Sciences·G L Craviso, J M Musacchio
Feb 21, 1977·Biochemical and Biophysical Research Communications·N MarksA Neidle
Oct 1, 1972·Journal of Neurochemistry·H Y Yang, N H Neff
Jan 1, 1980·Naunyn-Schmiedeberg's Archives of Pharmacology·H Osborne, A Herz

❮ Previous
Next ❯

Citations

Feb 20, 1984·Brain Research·G PasinettiM Trabucchi
Feb 20, 1984·Brain Research·L LucchiM Trabucchi
Nov 19, 1982·European Journal of Pharmacology·S DasJ J Ghosh
Apr 23, 1982·European Journal of Pharmacology·J L Vaught, R E Chipkin
Apr 23, 1982·European Journal of Pharmacology·T L Yaksh, G J Harty
Aug 5, 1983·European Journal of Pharmacology·M AltsteinS Blumberg
Sep 17, 1984·European Journal of Pharmacology·C Llorens-Cortes, J C Schwartz
Nov 5, 1985·European Journal of Pharmacology·G WaksmanB Roques
Mar 31, 1987·European Journal of Pharmacology·J G Van AmsterdamW Soudijn
Dec 8, 1986·Life Sciences·Z H Galina, A J Kastin
May 1, 1991·Pharmacology, Biochemistry, and Behavior·M L ProiettiA Scotti de Carolis
Nov 1, 1982·Peptides·G A OlsonD H Coy
Jan 1, 1988·Neurochemistry International·G M LittlewoodA J Turner
Oct 1, 1994·Progress in Neuro-psychopharmacology & Biological Psychiatry·S Sagratella
Jan 1, 1982·Progress in Neurobiology·R C Frederickson, L E Geary
Jul 27, 1984·Neuroscience Letters·D Liston, J Rossier
Oct 1, 1985·Neuroscience·J L MaderdrutR W Oppenheim
Apr 20, 2002·The Biochemical Journal·Christiane RoseTanja Ouimet

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.